HROW Q2 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14M+30.2% YoY

Gross Profit

$8M61.3% margin

Operating Income

-$767,000-5.7% margin

Net Income

-$2M-17.6% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

$844,000

Free Cash Flow

$387,000

Stock-Based Comp.

$367,000

Balance Sheet

Total Assets

$65M

Total Liabilities

$30M

Stockholders' Equity

$35M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+30.2%
Gross Profit	$8M	$6M	+33.1%
Operating Income	-$767,000	-$624,000	-22.9%
Net Income	-$2M	$3M	-194.3%

Revenue Segments

License Revenues

$7,000100%